Enanta Pharmaceuticals (ENTA) PT Lowered to $44 at SVB Leerink
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.44 -0.44%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
SVB Leerink analyst Roanna Ruiz lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $44.00 (from $58.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Greens (6547:JP) PT Raised to JPY3,800 at Nomura/Instinet
- Nihon Kohden Corp (6849:JP) PT Lowered to JPY1,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
